Fisher Asset Management LLC Has $5.55 Million Position in The Cooper Companies, Inc. $COO

Fisher Asset Management LLC cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 31.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 77,990 shares of the medical device company’s stock after selling 35,345 shares during the period. Fisher Asset Management LLC’s holdings in Cooper Companies were worth $5,550,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the business. Claret Asset Management Corp acquired a new position in shares of Cooper Companies during the second quarter worth approximately $233,000. Edgestream Partners L.P. grew its stake in shares of Cooper Companies by 109.3% in the second quarter. Edgestream Partners L.P. now owns 9,732 shares of the medical device company’s stock worth $693,000 after acquiring an additional 5,083 shares during the last quarter. River Road Asset Management LLC acquired a new position in Cooper Companies during the 2nd quarter valued at $40,421,000. Lido Advisors LLC boosted its holdings in Cooper Companies by 43.2% in the 2nd quarter. Lido Advisors LLC now owns 3,482 shares of the medical device company’s stock valued at $248,000 after purchasing an additional 1,051 shares during the period. Finally, New York State Common Retirement Fund boosted its holdings in Cooper Companies by 3.0% in the 2nd quarter. New York State Common Retirement Fund now owns 103,050 shares of the medical device company’s stock valued at $7,333,000 after purchasing an additional 3,000 shares during the period. Institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. The Goldman Sachs Group set a $64.00 price objective on shares of Cooper Companies and gave the company a “sell” rating in a research report on Wednesday, October 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cooper Companies in a report on Monday. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the stock an “equal weight” rating in a research report on Thursday, August 28th. Piper Sandler lowered their price objective on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Finally, Robert W. Baird cut their target price on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $84.77.

Insider Activity

In other news, Director Lawrence Erik Kurzius purchased 2,000 shares of the company’s stock in a transaction on Monday, September 29th. The shares were purchased at an average price of $68.39 per share, with a total value of $136,780.00. Following the purchase, the director directly owned 5,777 shares of the company’s stock, valued at $395,089.03. This trade represents a 52.95% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.98% of the stock is owned by corporate insiders.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $77.03 on Friday. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $104.47. The firm’s 50-day moving average price is $72.01 and its two-hundred day moving average price is $71.74. The stock has a market capitalization of $15.31 billion, a price-to-earnings ratio of 37.95, a P/E/G ratio of 1.87 and a beta of 1.05.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the previous year, the business posted $1.04 EPS. Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has authorized a share repurchase program on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.